CytomX Therapeutics director Charles S. Fuchs files initial beneficial ownership statement
CTMX•Director files initial Form 3
- CytomX Therapeutics director Charles S. Fuchs filed an initial Form 3 on July 30, 2026, covering his holdings in the company.
